Gastrointestinal Tumor – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Gastrointestinal Tumor – Drugs In Development, 2024 report and make more profitable business decisions.
Gastrointestinal (GI) tumors refer to abnormal growths or neoplasms that develop in various parts of the digestive system, which includes the esophagus, stomach, intestines (small and large), liver, gallbladder, and pancreas. These tumors can be benign (non-cancerous) or malignant (cancerous).
The Gastrointestinal Tumor drugs in development market research report provide comprehensive information on the therapeutics under development for Gastrointestinal Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Gastrointestinal Tumor and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Gastrointestinal Tumor | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 65 molecules, with 62 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Gastrointestinal Tumor therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Gastrointestinal Tumor pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Gastrointestinal Tumor treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Akeso IncAlphamab Oncology
Arbele Ltd
Aslan Pharmaceuticals Ltd
AstraZeneca Plc
BeiGene Ltd
Beijing Konruns Pharmaceutical Co Ltd
Bexion Pharmaceuticals Inc
Bold Therapeutics Inc
Bristar Immunotech Biotechnology Co Ltd
Centrymed Pharmaceutical Inc
Coherent Biopharma
Curegenix Inc
Diverse Biotech Inc
Eisai Co Ltd
Elicio Therapeutics Inc
Elpiscience Biopharma Ltd
Ex Seven Research LLC
FutureGen Biopharm Technology Co Ltd
Gansu Provincial People's Hospital
Genor BioPharma Co Ltd
GV20 Therapeutics LLC
Hutchison MediPharma Ltd
Imugene Ltd
Incyte Corp
Innovent Biologics Inc
Inspirna Inc
Kexing Biopharm Co Ltd
LaNova Medicines Ltd
LaunXP Biomedical Co Ltd
Merck & Co Inc
Minneamrita Therapeutics LLC
NB Health Laboratory Co Ltd
Peking University
Pfizer Inc
Portage Biotech Inc
Processa Pharmaceuticals Inc
RedHill Biopharma Ltd
Shandong Boan Biotechnology Co Ltd
Shanghai Gencells Therapeutics Co Ltd
Shanghai Grit Biotechnology Inc
Shanghai Yuyao Biotechnology Ltd
Shorla Oncology
Stemline Therapeutics Inc
Suzhou Immunofoco Biotechnology Co Ltd
Systimmune Inc
T-Knife GmbH
Tachyon Therapeutics Inc
Taiho Oncology Inc
Teclison Ltd
TOT Biopharm Co Ltd
TransThera Sciences (Nanjing) Inc
Wuhan Binhui Biopharmaceutical Co Ltd
Xiangxue Pharmaceutical Co Ltd
XtalPi Inc
Xuzhou Medical University
Zhejiang Teruisi Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Gastrointestinal Tumor reports